Google

Tuesday, April 3, 2007

Ibuprofen best option for acute pain in children with musculoskeletal injuries?

Ibuprofen best option for acute pain in children with musculoskeletal injuries?

A double-blind study published in Pediatrics has investigated the efficacy of single dose paracetamol, codeine and ibuprofen for children presenting with pain from acute musculoskeletal injuries.

Outcome data was presented for 300 patients aged 6 to 17 years who had suffered pain from a musculoskeletal injury (to extremities, neck, and back) that occurred in the preceding 48 hours before presentation in the emergency department.

Patients were randomised to receive either 15 mg/kg paracetamol (n=100), 10 mg/kg ibuprofen (n=100), or 1 mg/kg codeine (n=100).

The primary outcome was change in pain from baseline to 60 minutes after treatment with study medication as measured by using a visual analogue scale.

The researchers reported that:

  • Patients in the ibuprofen group had a significantly greater improvement in pain score (mean decrease: 24 mm) than those in the codeine group (mean decrease: 11 mm; p<0.001) p="0.001)" p="0.98).
  • At 60 minutes more patients in the ibuprofen group achieved adequate analgesia (as defined by a visual analogue scale <30mm) p="0.85);" p="0.026);" p="0.006).">
  • There was no significant difference between patients in the codeine and acetaminophen groups in the change in pain score at any time period or in the number of patients achieving adequate analgesia.
The researchers concluded that for the treatment of acute traumatic musculoskeletal injuries, ibuprofen provides the best analgesia among the three study medications.

Pediatrics 2007; 119: 460-7 (link to abstract)

1 comment:

buy caverta 50 mg online said...

sildenafil 50 mg is used to treat erectile dysfunction in adult men. it works by relaxing the blood vessels in the penis thereby allowing the blood to flow into the penis when the person is sexually excited. It belongs to a group of medicines known as phosphodiesterase type 5 PDE 5 inhibitors.